Home/Filings/4/0001562180-24-004338
4//SEC Filing

MORRIS DEBRA L 4

Accession 0001562180-24-004338

CIK 0001819253other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:05 PM ET

Size

12.1 KB

Accession

0001562180-24-004338

Insider Transaction Report

Form 4
Period: 2024-05-21
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-05-21+9,11039,110 total
  • Exercise/Conversion

    Deferred Settlement RSU

    2024-05-219,1100 total
    Class A Common Stock (9,110 underlying)
  • Award

    Deferred Settlement RSU

    2024-05-21+10,39510,395 total
    Class A Common Stock (10,395 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-05-21+65,258153,657 total
    Exercise: $5.57Exp: 2034-05-20Class A Common Stock (65,258 underlying)
Footnotes (4)
  • [F1]Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
  • [F2]The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2024 or the date of the Reporting Person's separation from service.
  • [F3]The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
  • [F4]All shares subject to the option award shall vest on the earlier of May 21, 2025 or the day prior to the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Issuer

biote Corp.

CIK 0001819253

Entity typeother

Related Parties

1
  • filerCIK 0001838995

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:05 PM ET
Size
12.1 KB